QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer
Clinical trial NCT07286240 · RECRUITING
Trial details
- NCT number
- NCT07286240
- Sponsor
- Affiliated Cancer Hospital & Institute of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-15
- Primary completion
- 2027-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.